Kelly Fitzgerald, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases (NCT07043608) | Kelly Fitzgerald, MD | 2026-06-10 |
Track Kelly Fitzgerald, MD automatically
Every clearance here is in the API, with alerts when new ones post.